Across TCGA pan-cancer cohorts, LINC01962 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC01962’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01962 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01962 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.
KIRC, KIRP, and COAD are the cancer types where LINC01962 tumor–normal differential expression is most reproducible.